Aspire Biopharma Holdings, Inc. 8-K

Accession 0001493152-26-016979

Filing information

CIK: 0001847345
Report date: 2026-04-16
Filing date: 2026-04-16
Form: 8-K
Primary document: form8-k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.